研究院成立背景及宗旨

华瑞分子生物医学研究院成立于2007年11月，其宗旨是支持研究和开发的生物标志物在临床应用和疾病早期风险评估。本院依托瑞典乌普萨拉生物医学中心 (Uppsala Biomedical Center-BMC) 和瑞典斯德哥尔摩大学在分子生物医学的研究团队，集中研究胸苷激酶1 --  一个优选的肿瘤细胞增殖标志物用于健康检查，肿瘤患者的预后和治疗效果的监视；研究一种特殊的氧化应激标志物，是有用的判断健康人的自由基水平，并鉴定肿瘤患者放射敏感性差异，给予放疗的癌症患者最佳治疗剂量。

自研究院成立以来，与国内和国际大学、医院已经完成和正在进行16项科研合作项目，已发表14篇科学论文，其中5篇国际科学论文，9篇国内科学论文，并呈送5份文稿到国际杂志。

Uppsala Biomedical Center-BMC

Uppsala Biomedical Center - BMC - is located at the old artillery field, in the block namned "Rosendal", just opposite the old military campus of Uppsala . BMC harbours scientific research and education in area such as biology, chemistry, medicine, pharmacy and domestic sciences. The main part of the research departments belongs to Uppsala University, but BMC also harbours units from the Swedish University of Agricultural Science and the Ludwig Institute for Cancer Research.

Stockholm University Research Centre

Research within the humanities, law, and the social and natural sciences at Stockholm University is internationally renowned, with a cross-disciplinary focus that allows flexible interactions between departments. Fifteen of the University's research areas have been specially chosen to profile the University, each nationally-leading and of internationally recognised status.